Welcome to our dedicated page for GAMEON ENTMT TECHNOLOGIES news (Ticker: $GMETF), a resource for investors and traders seeking the latest updates and insights on GAMEON ENTMT TECHNOLOGIES stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect GAMEON ENTMT TECHNOLOGIES's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of GAMEON ENTMT TECHNOLOGIES's position in the market.
GameOn (CSE: GET) (OTCQB: GMETF) has been granted a management cease trade order (MCTO) by the British Columbia Securities Commission due to a delay in filing its annual financial statements. The delay is caused by additional due diligence related to new commercial agreements and blockchain grants. The MCTO restricts the CEO and CFO from trading until the filings are submitted. The company expects to file the annual statements by June 28, 2024, and is complying with alternative information guidelines in the meantime.